EMDR in the Treatment of Specific Phobia.

This study has been completed.
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184145
First received: September 10, 2005
Last updated: January 22, 2008
Last verified: January 2008

September 10, 2005
January 22, 2008
June 2004
September 2004   (final data collection date for primary outcome measure)
Behavioral Approach Test towards the feared animal. [ Time Frame: Before and after each treatment ] [ Designated as safety issue: No ]
  • Behavioral Approach Test towards the feared animal.
  • Scores on self-report questionnaires on phobic symptoms.
Complete list of historical versions of study NCT00184145 on ClinicalTrials.gov Archive Site
  • Scores on self-report questionnaires on phobic symptoms [ Time Frame: Before and after both treatments ] [ Designated as safety issue: No ]
  • Neuropsychological function [ Time Frame: Before first treatment, some measures also before second treatment ] [ Designated as safety issue: No ]
  • Cognitive strategies [ Time Frame: Before both treatments ] [ Designated as safety issue: No ]
  • BDI (Beck Depression Inventory)
  • SCL-90-R (Symptom Checklist-90-Revised)
  • MCMI-II (Millon Clinical Multiaxial Inventory)
  • Neuropsychological function
  • Cognitive strategies
Not Provided
Not Provided
 
EMDR in the Treatment of Specific Phobia.
EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.

The purpose for this study is to determine whether EMDR is effective in the treatment of specific (animal) phobia.

Aims: To test the hypothesis that one session EMDR is more effective for the treatment of specific (animal) phobia than relaxation immediately after treatment and at follow-up. Secondly to test whether an additional one-session exposure therapy offered to both treatment groups (EMDR patients and relaxation patients) improves outcome in the EMDR-group and results in equal outcome for both treatment groups.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Specific Phobia
  • Other: EMDR (Eye Movement Desensitization and Reprocessing)
    Psychotherapy which is approved for PTSD.
  • Other: Exposure therapy
    All participants in the study received exposure therapy som second treatment. Exposure therapy is the therapy of choice for animal phobia.
Experimental: EMDR
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Interventions:
  • Other: EMDR (Eye Movement Desensitization and Reprocessing)
  • Other: Exposure therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
September 2004
September 2004   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Specific (Animal) Phobia

Exclusion Criteria:

  • Current or past psychotic disorder
  • Current substance dependence or abuse
  • Serious physical illness
  • Active suicidal behavior
  • Bipolar affective disorder
  • Pregnancy
Both
15 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00184145
EPLK-2004
Yes
Ludger Kaiser, Mental Health Department, St. Olavs University Hospital Trondheim
Norwegian University of Science and Technology
St. Olavs Hospital
Principal Investigator: Ludger Kaiser, Doctor
Norwegian University of Science and Technology
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP